ABSTRACT
OBJECTIVE: There are concerns that lumbar spine imaging represents low value care. Our aim was to examine the use of lumbar spine imaging [radiography, computed tomography (CT), magnetic resonance imaging (MRI)] over 20 years, and costs and person-level characteristics of imaging in a large cohort of Australian women. METHODS: The Australian Longitudinal Study on Women's Health (ALSWH) is a longitudinal population-based survey of women randomly selected from national health insurance scheme (Medicare) database. This study examined 13458 women born in 1973-1978 who consented to link their ALSWH and Medical Benefits Scheme records. Self-reported data on demographics, body mass index, depression, physical and mental health, and back pain were collected in each survey performed in 1996, 2000, 2003, 2006, 2009, 2012, and 2015. Data on lumbar spine imaging from 1996 to 2015 were obtained from the Medical Benefits Scheme database. RESULTS: 38.9% of women underwent some form of lumbar spine imaging over 20 years. While radiography increased from 1996 to 2011 and decreased thereafter, CT and MRI continued to increase from 1996 to 2015. In women with self-reported back pain, depression and poorer physical health were associated with imaging, with no significant differences in types of imaging. Based on imaging rates in ALSWH, the estimated costs for Australian women aged 30-39 years were AU$51,735,649 over 2011-2015. CONCLUSIONS: Lumbar spine imaging was common in population-based Australian women, with rates increasing over 20 years. Depression and poor physical health were associated with lumbar spine imaging. Raising awareness of this in clinicians is likely to result in significant cost savings if clinical guidelines are followed, with the potential of freeing resources for high value care and health outcomes.
Subject(s)
Lumbosacral Region/diagnostic imaging , Magnetic Resonance Imaging/economics , Adult , Aged , Australia/epidemiology , Back Pain/psychology , Costs and Cost Analysis , Female , Humans , Longitudinal Studies , Lumbar Vertebrae/diagnostic imaging , Magnetic Resonance Imaging/statistics & numerical data , Magnetic Resonance Imaging/trends , Middle Aged , National Health Programs , Radiography , Women's HealthABSTRACT
INTRODUCTION: Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) is a new technology that provides a clinically efficacious and minimally invasive alternative to conventional microsurgical resection. However, little data exist on how costs compare to traditional open surgery. The goal of this paper is to investigate the cost-effectiveness of MRgLITT in the treatment of pediatric epilepsy. METHODS: We retrospectively analyzed the medical records of pediatric patients who underwent MRgLITT via the Visualase® thermal therapy system (Medtronic, Inc., Minneapolis, MN, USA) between December 2013 and September 2017. Direct costs associated with preoperative, operative, and follow-up care were extracted. Benefit was calculated in quality-adjusted life years (QALYs), and the cost-effectiveness was derived from the discounted total direct costs over QALY. Sensitivity analysis on 4 variables was utilized to assess the validity of our results. RESULTS: Twelve consecutive pediatric patients with medically refractory epilepsy underwent MRgLITT procedures. At the last postoperative follow-up, 8 patients were seizure free (Engel I, 66.7%), 2 demonstrated significant improvement (Engel II, 16.7%), and 2 patients showed worthwhile improvement (Engel III, 16.7%). The average cumulative discounted QALY was 2.11 over the lifetime of a patient. Adjusting for inflation, MRgLITT procedures had a cost-effectiveness of USD 22,211 per QALY. Our sensitivity analysis of cost variables is robust and supports the procedure to be cost--effective. CONCLUSION: Our data suggests that MRgLITT may be a cost-effective alternative to traditional surgical resection in pediatric epilepsy surgery.
Subject(s)
Cost-Benefit Analysis/methods , Drug Resistant Epilepsy/surgery , Hyperthermia, Induced/methods , Intraoperative Neurophysiological Monitoring/methods , Laser Therapy/methods , Magnetic Resonance Imaging/methods , Adolescent , Child , Child, Preschool , Drug Resistant Epilepsy/diagnostic imaging , Drug Resistant Epilepsy/economics , Extracellular Fluid/physiology , Female , Follow-Up Studies , Humans , Hyperthermia, Induced/economics , Intraoperative Neurophysiological Monitoring/economics , Laser Therapy/economics , Magnetic Resonance Imaging/economics , Male , Retrospective Studies , Young AdultABSTRACT
STUDY DESIGN: Retrospective, observational study. OBJECTIVE: To examine the costs associated with nonoperative management (diagnosis and treatment) of cervical radiculopathy in the year prior to anterior cervical discectomy and fusion (ACDF). SUMMARY OF BACKGROUND DATA: While the costs of operative treatment have been previously described, less is known about nonoperative management costs of cervical radiculopathy leading up to surgery. METHODS: The Humana claims dataset (2007-2015) was queried to identify adult patients with cervical radiculopathy that underwent ACDF. Outcome endpoint was assessment of cumulative and per-capita costs for nonoperative diagnostic (x-rays, computed tomographic [CT], magnetic resonance imaging [MRI], electromyogram/nerve conduction studies [EMG/NCS]) and treatment modalities (injections, physical therapy [PT], braces, medications, chiropractic services) in the year preceding surgical intervention. RESULTS: Overall 12,514 patients (52% female) with cervical radiculopathy underwent ACDF. Cumulative costs and per-capita costs for nonoperative management, during the year prior to ACDF was $14.3 million and $1143, respectively. All patients underwent at least one diagnostic test (MRI: 86.7%; x-ray: 57.5%; CT: 35.2%) while 73.3% patients received a nonoperative treatment. Diagnostic testing comprised of over 62% of total nonoperative costs ($8.9 million) with MRI constituting the highest total relative spend ($5.3 million; per-capita: $489) followed by CT ($2.6 million; per-capita: $606), x-rays ($0.54 million; per-capita: $76), and EMG/NCS ($0.39 million; per-capita: $467). Conservative treatments comprised of 37.7% of the total nonoperative costs ($5.4 million) with injections costs constituting the highest relative spend ($3.01 million; per-capita: $988) followed by PT ($1.13 million; per-capita: $510) and medications (narcotics: $0.51 million, per-capita $101; gabapentin: $0.21 million, per-capita $93; NSAIDs: 0.107 million, per-capita $47), bracing ($0.25 million; per-capita: $193), and chiropractic services ($0.137 million; per-capita: $193). CONCLUSION: The study quantifies the cumulative and per-capital costs incurred 1-year prior to ACDF in patients with cervical radiculopathy for nonoperative diagnostic and treatment modalities. Approximately two-thirds of the costs associated with cervical radiculopathy are from diagnostic modalities. As institutions begin entering into bundled payments for cervical spine disease, understanding condition specific costs is a critical first step. LEVEL OF EVIDENCE: 3.
Subject(s)
Cervical Vertebrae , Health Care Costs , Insurance Claim Reporting/economics , Neurosurgical Procedures/economics , Radiculopathy/economics , Radiculopathy/therapy , Adult , Aged , Cervical Vertebrae/diagnostic imaging , Cervical Vertebrae/surgery , Cohort Studies , Databases, Factual/economics , Databases, Factual/trends , Diskectomy/economics , Diskectomy/trends , Female , Health Care Costs/trends , Humans , Insurance Claim Reporting/trends , Magnetic Resonance Imaging/economics , Magnetic Resonance Imaging/trends , Male , Manipulation, Chiropractic/economics , Manipulation, Chiropractic/trends , Middle Aged , Neurosurgical Procedures/trends , Physical Therapy Modalities/economics , Physical Therapy Modalities/trends , Radiculopathy/diagnostic imaging , Retrospective Studies , Spinal Fusion/economics , Spinal Fusion/trends , Tomography, X-Ray Computed/economics , Tomography, X-Ray Computed/trends , Treatment OutcomeABSTRACT
INTRODUCTION: A short-term radiologic follow-up after a benign breast biopsy or fine needle aspiration (FNA) is recommended in many guidelines. However, the current trend is to reduce imaging investigations, radiation dose and costs. The objectives of this study were to evaluate the cancer detection rate at short-term follow-up and to estimate its cost. METHODS: We retrospectively assessed all consecutive patients referred to our 'one-stop' breast unit between 2004 and 2012, with a benign histological or cytological result and at least one short-term follow-up within 3-12 months after the initial diagnosis. We evaluated the number of cancers detected, as well as the mean cost to detect each cancer and per patient. RESULTS: About 1366 patients were eligible for this study. Ten patients were diagnosed with cancers (0.73%) at short-term follow-up; six of 10 were low-grade tumours or ductal carcinoma in situ. The cost for detecting one cancer was 19,043, with mean cost per patient of 139. CONCLUSION: The cancer detection rate at short-term follow-up after benign biopsy or FNA was low and was similar to that of most national screening programs. The cost of cancer detection appeared high, considering that most cancers were indolent. This suggests that radiologic follow-up could reasonably be carried out at a later point in time.
Subject(s)
Breast Neoplasms/diagnostic imaging , Breast Neoplasms/economics , Carcinoma, Intraductal, Noninfiltrating/diagnostic imaging , Carcinoma, Intraductal, Noninfiltrating/economics , Delivery of Health Care, Integrated/economics , Early Detection of Cancer/economics , Health Care Costs , Mammography/economics , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy , Breast Neoplasms/pathology , Carcinoma, Intraductal, Noninfiltrating/pathology , Cost-Benefit Analysis , Early Detection of Cancer/methods , Female , Humans , Magnetic Resonance Imaging/economics , Mammography/methods , Middle Aged , Neoplasm Grading , Predictive Value of Tests , Prognosis , Program Evaluation , Retrospective Studies , Time Factors , Ultrasonography, Mammary/economics , Young AdultABSTRACT
BACKGROUND: The National Comprehensive Cancer Network recommends that women who carry gene variants that confer substantial risk for breast cancer consider risk-reduction strategies, that is, enhanced surveillance (breast magnetic resonance imaging and mammography) or prophylactic surgery. Pathogenic variants can be detected in women with a family history of breast or ovarian cancer syndromes by multigene panel testing. OBJECTIVES: To investigate whether using a seven-gene test to identify women who should consider risk-reduction strategies could cost-effectively increase life expectancy. METHODS: We estimated effectiveness and lifetime costs from a payer perspective for two strategies in two hypothetical cohorts of women (40-year-old and 50-year-old cohorts) who meet the National Comprehensive Cancer Network-defined family history criteria for multigene testing. The two strategies were the usual test strategy for variants in BRCA1 and BRCA2 and the seven-gene test strategy for variants in BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, and PALB2. Women found to have a pathogenic variant were assumed to undergo either prophylactic surgery or enhanced surveillance. RESULTS: The incremental cost-effectiveness ratio for the seven-gene test strategy compared with the BRCA1/2 test strategy was $42,067 per life-year gained or $69,920 per quality-adjusted life-year gained for the 50-year-old cohort and $23,734 per life-year gained or $48,328 per quality-adjusted life-year gained for the 40-year-old cohort. In probabilistic sensitivity analysis, the seven-gene test strategy cost less than $100,000 per life-year gained in 95.7% of the trials for the 50-year-old cohort. CONCLUSIONS: Testing seven breast cancer-associated genes, followed by risk-reduction management, could cost-effectively improve life expectancy for women at risk of hereditary breast cancer.
Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/genetics , Early Detection of Cancer/economics , Gene Expression Profiling/economics , Genetic Testing/economics , Health Care Costs , Life Expectancy , Quality-Adjusted Life Years , Adult , Age Factors , Aged , Aged, 80 and over , Breast Neoplasms/economics , Breast Neoplasms/therapy , Cost-Benefit Analysis , Decision Support Techniques , Early Detection of Cancer/methods , Female , Genetic Predisposition to Disease , Heredity , Humans , Magnetic Resonance Imaging/economics , Mammography/economics , Mastectomy/economics , Middle Aged , Models, Economic , Patient Selection , Phenotype , Predictive Value of Tests , Prognosis , Risk Assessment , Risk Factors , Watchful Waiting/economicsABSTRACT
Practical magnetic resonance imaging for use in investigative and preclinical toxicology studies is now feasible. Newly developed, self-containing imaging systems provide an efficient and cost-effective means to rapidly obtain in vivo and ex vivo magnetic resonance imaging images to improve how we perform toxicology and toxicologic pathology.
Subject(s)
Cost-Benefit Analysis , Drug Evaluation, Preclinical , Drug-Related Side Effects and Adverse Reactions , Magnetic Resonance Imaging/instrumentation , Animals , Magnetic Resonance Imaging/economicsABSTRACT
OBJECTIVE: To evaluate the surveillance recommendations for early-stage testis cancer and the risk of secondary malignancies due to increased radiation exposure. MATERIALS AND METHODS: Using National Comprehensive Cancer Network (NCCN) guidelines 2012 and 2014 for early-stage testicular cancer, the numbers of abdominal and pelvic computed tomography scans (CTAPs) and chest radiographies were calculated, and lifetime attributable risk for secondary malignancy was estimated using Biologic Effects of Ionizing Radiation VII organ-specific model for solid organ malignancy based on the initial age of exposure. Cost was based on the Centers for Medicare and Medicaid Services' cost estimates of CTAP and magnetic resonance imaging (MRI). RESULTS: The 2012 NCCN protocol uses a maximum of 17 CTAPs over 6 years, whereas 2014 guidelines suggest a maximum of 13 CTAPs. The radiation dosage in 2014 guidelines is decreased by 25% compared to the 2012 NCCN guidelines. The minimum number of CTAPs under the 2014 NCCN protocol reduced radiation dose by 38% compared to the maximum number, this compared to about 50% decrease from the 2012 NCCN guidelines. The median cost for a single CTAP with contrast is $369.30; median cost for a single MRI with contrast is $772.18. As compared to the 2012 protocol, the 2014 guidelines reduced CTAP cost by approximately 24%-54% for minimum and maximum CTAPs allowed. CONCLUSION: There is low, however nonzero, risk of secondary malignancy for surveillance in stage I testicular cancer. There is also a significant cost difference between protocols as well as between CT and MRI modalities.
Subject(s)
Magnetic Resonance Imaging/adverse effects , Magnetic Resonance Imaging/economics , Neoplasms, Germ Cell and Embryonal/diagnosis , Neoplasms, Radiation-Induced/epidemiology , Radiation Dosage , Testicular Neoplasms/diagnosis , Tomography, X-Ray Computed/adverse effects , Tomography, X-Ray Computed/economics , Watchful Waiting/economics , Adult , Costs and Cost Analysis , Humans , Male , Neoplasm Staging , Risk Assessment , Young AdultABSTRACT
BACKGROUND: Diagnostic imaging represents the fastest growing segment of costs in the US health system. This study investigated the cost-effectiveness of alternative diagnostic approaches to meniscus tears of the knee, a highly prevalent disease that traditionally relies on MRI as part of the diagnostic strategy. PURPOSE: To identify the most efficient strategy for the diagnosis of meniscus tears. STUDY DESIGN: Economic and decision analysis; Level of evidence, 1. METHODS: A simple-decision model run as a cost-utility analysis was constructed to assess the value added by MRI in various combinations with patient history and physical examination (H&P). The model examined traumatic and degenerative tears in 2 distinct settings: primary care and orthopaedic sports medicine clinic. Strategies were compared using the incremental cost-effectiveness ratio (ICER). RESULTS: In both practice settings, H&P alone was widely preferred for degenerative meniscus tears. Performing MRI to confirm a positive H&P was preferred for traumatic tears in both practice settings, with a willingness to pay of less than US$50,000 per quality-adjusted life-year. Performing an MRI for all patients was not preferred in any reasonable clinical scenario. The prevalence of a meniscus tear in a clinician's patient population was influential. For traumatic tears, MRI to confirm a positive H&P was preferred when prevalence was less than 46.7%, with H&P preferred above that. For degenerative tears, H&P was preferred until the prevalence reaches 74.2%, and then MRI to confirm a negative was the preferred strategy. In both settings, MRI to confirm positive physical examination led to more than a 10-fold lower rate of unnecessary surgeries than did any other strategy, while MRI to confirm negative physical examination led to a 2.08 and 2.26 higher rate than H&P alone in primary care and orthopaedic clinics, respectively. CONCLUSION: For all practitioners, H&P is the preferred strategy for the suspected degenerative meniscus tear. An MRI to confirm a positive H&P is preferred for traumatic tears for all practitioners. Consideration should be given to implementing alternative diagnostic strategies as well as enhancing provider education in physical examination skills to improve the reliability of H&P as a diagnostic test. CLINICAL RELEVANCE: Alternative diagnostic strategies that do not include the use of MRI may result in decreased health care costs without harm to the patient and could possibly reduce unnecessary procedures.
Subject(s)
Arthroscopy/statistics & numerical data , Magnetic Resonance Imaging/economics , Orthopedics/economics , Primary Health Care/economics , Tibial Meniscus Injuries , Unnecessary Procedures/statistics & numerical data , Adult , Aged , Cost-Benefit Analysis , Decision Support Techniques , False Negative Reactions , False Positive Reactions , Female , Humans , Male , Medical History Taking , Middle Aged , Orthopedics/methods , Orthopedics/statistics & numerical data , Physical Examination , Practice Patterns, Physicians' , Prevalence , Primary Health Care/methods , Primary Health Care/statistics & numerical data , Quality-Adjusted Life Years , Reproducibility of Results , Rupture/diagnosis , Rupture/economics , Rupture/epidemiology , Rupture, Spontaneous/diagnosis , Rupture, Spontaneous/economics , Rupture, Spontaneous/epidemiology , Sensitivity and Specificity , United States , Young AdultABSTRACT
OBJECTIVE: The study objective was to assess the impact of a provider-led, technology-enabled radiology medical management program on high-cost imaging use. METHODS: This study was performed in the ambulatory setting of an integrated healthcare system. After negotiating a risk contract with a major commercial payer, we created a physician-led radiology medical management program to help address potentially inappropriate high-cost imaging use. The radiology medical management program was enabled by a computerized physician order entry system with integrated clinical decision support and accountability tools, including (1) mandatory peer-to-peer consultation with radiologists before order completion when test utility was uncertain on the basis of order requisition; (2) quarterly practice pattern variation reports to providers; and (3) academic detailing for targeted outliers. The primary outcome measure was intensity of high-cost imaging, defined as the number of outpatient computed tomography (CT), magnetic resonance imaging (MRI), and nuclear cardiology studies per 1000 patient-months in the payer's panel. Chi-square test was used to assess trends. RESULTS: In 1.8 million patient-months from January 2004 to December 2009, 50,336 eligible studies were performed (54.1% CT, 40.3% MRI, 5.6% nuclear cardiology). There was a 12.0% sustained reduction in high-cost imaging intensity over the 5-year period (P < .001). The number of CT studies performed decreased from 17.5 per 1000 patient-months to 14.5 (P < .01); nuclear cardiology examinations decreased from 2.4 to 1.4 (P < .01) per 1000 patient-months. The MRI rate remained unchanged at 11 studies per 1000 patient-months. CONCLUSION: A provider-led radiology medical management program enabled through health information technology and accountability tools may produce a significant reduction in high-cost imaging use.
Subject(s)
Diagnostic Imaging/statistics & numerical data , Medical Order Entry Systems , Practice Patterns, Physicians'/standards , Radiology/methods , Unnecessary Procedures , Adult , Cardiac Imaging Techniques/economics , Cardiac Imaging Techniques/statistics & numerical data , Delivery of Health Care, Integrated/economics , Delivery of Health Care, Integrated/methods , Diagnostic Imaging/economics , Female , Humans , Magnetic Resonance Imaging/economics , Magnetic Resonance Imaging/statistics & numerical data , Male , Medical Informatics/methods , Practice Patterns, Physicians'/economics , Radiology/education , Radionuclide Imaging/economics , Radionuclide Imaging/statistics & numerical data , Referral and Consultation , Tomography, X-Ray Computed/economics , Tomography, X-Ray Computed/statistics & numerical dataABSTRACT
BACKGROUND: An increasing number of modern imaging procedures are being applied for the diagnosis of appendicitis. We compared one hundred consecutive appendectomies of the years 1988, 1998 and 2008 concerning reliability of preoperative diagnosis and resulting costs. METHODS: We analysed the first one hundred consecutive patients undergoing appendectomy during the years 1988, 1998 and 2008, 59 % were female and 41 % male. The average age was 26 years, the average BMI 21.09. The costs and results of radiological investigations (US, CT, MRI, X-ray) have been compared in all patients. The sensitivity of ultrasound and CT scan in preoperative diagnosis has been analysed. RESULTS: The number of preoperative imaging procedures for the diagnosis of appendicitis has increased over the last two decades. Simultaneously increased the costs (total costs and costs per partient) for imaging procedures. 2008 the costs were 10 times higher than 1988. CT had a higher sensitivity (77 %) in the diagnosis of appendicitis than ultrasound (33 %). The number of operations because of subacute and chronic appendicitis was lower in 2008 (34 of 100) compared with 1988 (80 of 100) and 1998 (60 of 100). In 2008 (14) we found a higher number of gangrenous and perforated appendicitis compared to 1988 (2) and 1998 (5). The majority (50 of 100) of patients in the group with acute and phlegmonous appendicitis was found in 2008. CONCLUSION: There has been an increase in the use of preoperative imaging procedures in the diagnosis of appendicitis during the last 20 years. This causes more costs in the public health system. Ultrasound as the standard imaging method for diagnosing appendicitis showed poor sensitivity. CT scans had good results concerning sensitivity, but are expensive and involve exposure to radiation for the patient.
Subject(s)
Appendicitis/diagnosis , Appendicitis/surgery , Diagnostic Imaging/economics , Diagnostic Imaging/trends , Adult , Appendectomy/economics , Appendicitis/economics , Austria , Cost-Benefit Analysis , Diagnosis, Differential , Emergency Service, Hospital/economics , Female , Humans , In Vitro Techniques , Laparoscopy/economics , Magnetic Resonance Imaging/economics , Male , National Health Programs/economics , National Health Programs/trends , Sensitivity and Specificity , Tomography, X-Ray Computed/economics , Ultrasonography/economics , Young AdultABSTRACT
PURPOSE: Detailed evaluation and cost analysis of a cranial contrast-enhanced MRI (c-ceMRI) in outpatients, inpatients, patients in an intensive care unit and children under anesthesia. MATERIALS AND METHODS: Based on a detailed process-oriented model, we calculated the cost of a cranial MRI for the four situations mentioned above. A comprehensive evaluation of the overhead and personnel costs was performed. RESULTS: We performed 5108 MRI examinations on 2 scanners in the year 2008. 2150 examinations (42 %) were identified as c-ceMRI. For inpatients we calculated a total cost of 242.46 per examination with a personnel cost of 81.71 for the radiological department. In outpatients we calculated total costs of 181.97 with radiological personnel costs of 68.67. Patients coming from an intensive care unit were treated by an intensive care team, which resulted in total costs of 416.58 with 283 in costs for radiological personnel (32.8 %). MRI examinations of children under anesthesia resulted in costs of 616.79 for the hospital, of which 285.78 were radiological personnel costs (34.5 %). CONCLUSION: In this study we evaluated for the first time different radiological scenarios of a c-ceMRI at a university hospital. Considering the present reimbursement situation, all outpatients covered by statutory health insurance resulted in a deficit for the hospital. Particularly high costs for patients in intensive care units as well as for children under anesthesia have to be taken into account and are currently not adequately covered by care providers.
Subject(s)
Brain/pathology , Contrast Media/economics , Hospitals, University/economics , Image Processing, Computer-Assisted/economics , Magnetic Resonance Imaging/economics , Adult , Ambulatory Care/economics , Child , Contrast Media/administration & dosage , Costs and Cost Analysis , Germany , Hospital Costs/statistics & numerical data , Humans , Insurance Coverage/economics , Intensive Care Units/economics , National Health Programs/economics , Patient Care Team/economics , Radiology Department, Hospital/economics , Reimbursement Mechanisms/economics , Uncompensated Care/economicsSubject(s)
Brain Diseases/diagnosis , Brain Diseases/physiopathology , Brain/physiopathology , Ethics, Medical , Ethics, Research , Magnetic Resonance Imaging/ethics , Neurosciences/ethics , Patient Care Team/ethics , Unnecessary Procedures/ethics , Brain/pathology , Cost-Benefit Analysis , Germany , Humans , Incidental Findings , Magnetic Resonance Imaging/economics , Mass Screening/economics , Mass Screening/ethics , National Health Programs/economics , National Health Programs/ethics , Neurosciences/economics , Patient Care Team/economics , Physician-Patient Relations/ethics , Unnecessary Procedures/economicsABSTRACT
PURPOSE: To compare the direct costs of two diagnostic algorithms for pretherapeutic TNM staging of rectal cancer. MATERIALS AND METHODS: In a study including 33 patients (mean age: 62.5 years), the direct fixed and variable costs of a sequential multimodal algorithm (rectoscopy, endoscopic and abdominal ultrasound, chest X-ray, thoracic/abdominal CT in the case of positive findings in abdominal ultrasound or chest X-ray) were compared to those of a novel algorithm of rectoscopy followed by MRI using a whole-body scanner. MRI included T 2w sequences of the rectum, 3D T 1w sequences of the liver and chest after bolus injection of gadoxetic acid, and delayed phases of the liver. The personnel work times, material items, and work processes were tracked to the nearest minute by interviewing those responsible for the process (surgeon, gastroenterologist, two radiologists). The costs of labor and materials were determined from personnel reimbursement data and hospital accounting records. Fixed costs were determined from vendor pricing. RESULTS: The mean MRI time was 55 min. CT was performed in 19/33 patients (57%) causing an additional day of hospitalization (costs 374 euro). The costs for equipment and material were higher for MRI compared to sequential algorithm (equipment 116 vs. 30 euro; material 159 vs. 60 euro per patient). The personnel costs were markedly lower for MRI (436 vs. 732 euro per patient). Altogether, the absolute cost advantage of MRI was 31.3% (711 vs. 1035 euro for sequential algorithm). CONCLUSION: Substantial savings are achievable with the use of whole-body MRI for the preoperative TNM staging of patients with rectal cancer.
Subject(s)
Algorithms , Endosonography/economics , Magnetic Resonance Imaging/economics , Proctoscopy/economics , Rectal Neoplasms/pathology , Tomography, Spiral Computed/economics , Ultrasonography/economics , Whole Body Imaging/economics , Adult , Aged , Aged, 80 and over , Contrast Media/economics , Costs and Cost Analysis , Female , Gadolinium DTPA/administration & dosage , Gadolinium DTPA/economics , Germany , Hospital Costs/statistics & numerical data , Humans , Length of Stay/economics , Liver/pathology , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Lung/pathology , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Male , Middle Aged , National Health Programs/economics , Neoplasm Staging , Personnel, Hospital/economics , Prospective StudiesABSTRACT
The purpose of this study was to assess the success of neurolinguistic programming in reducing the need for general anaesthesia in claustrophobic patients who require MRI and to consider the financial implications for health providers. This was a prospective study performed in 2006 and 2007 at a teaching hospital in England and comprised 50 adults who had unsuccessful MR examinations because of claustrophobia. The main outcome measures were the ability to tolerate a successful MR examination after neurolinguistic programming, the reduction of median anxiety scores produced by neurolinguistic programming, and models of costs for various imaging pathways. Neurolinguistic programming allowed 38/50 people (76%) to complete the MR examination successfully. Overall, the median anxiety score was significantly reduced following the session of neurolinguistic programming. In conclusion, neurolinguistic programming reduced anxiety and subsequently allowed MRI to be performed without resorting to general anaesthesia in a high proportion of claustrophobic adults. If these results are reproducible, there will be major advantages in terms of patient safety and costs.
Subject(s)
Anxiety/prevention & control , Magnetic Resonance Imaging/psychology , Neurolinguistic Programming , Phobic Disorders/prevention & control , Adolescent , Adult , Aged , Anesthesia, General/economics , Anesthesia, General/statistics & numerical data , England , Female , Humans , Magnetic Resonance Imaging/economics , Magnetic Resonance Imaging/methods , Male , Middle Aged , Patient Acceptance of Health Care , Phobic Disorders/psychology , Prospective Studies , Treatment Outcome , Young AdultABSTRACT
OBJECTIVES: The role of fused modality [F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography (PET/CT) in diagnosing and accurately staging patients with primary, metastatic, and recurrent head and neck (HN) cancer is evolving, and the clinical implications need to be further defined. A few retrospective studies have been performed, but adequate sample sizes are lacking because the number of HN cancer patients is relatively small. This study evaluates the positive predictive value (PPV), sensitivity, specificity, and accuracy of PET/CT in previously untreated HN cancer patients at a single tertiary care institution. The purpose of this study is to evaluate the role of this new technology in the management of previously untreated HN cancer patients. STUDY DESIGN: Retrospective cohort outcomes study at a tertiary National Cancer Institute Comprehensive Cancer Center. MATERIALS AND METHODS: Institutional review board exemption #4 (45 CFR 46.101 [4]) criteria were applied for and accepted by the office of responsible research practices at the Ohio State University College of Medicine. The authors identified 268 consecutive PET/CT examinations between March 2005 and January 2006 for HN cancer ordered by the two senior authors at the James Cancer Hospital and Solove Research Institute of the Ohio State University Medical Center. PET/CT examinations were interpreted by one of three neuroradiologists. PPV, sensitivity, specificity, accuracy, diagnostic upstaging, and treatment management changes were determined from subset analysis of 123 previously untreated patients with HN cancer. Synchronous lesions were detected in 10 patients with use of this modality. PET/CT was also used to help manage 22 patients with unknown primary HN cancer. The statistics were verified by comparing PET/CT results with surgical specimen histopathology. RESULTS: : PET/CT was true-positive in 82.9% (102/123), with a per patient PPV of 87.2% and a per lesion PPV of 89.4%. PET/CT was false-positive in 12.2% (15/123) of patients and had a false-positive rate of 8.3% when calculated per lesion. In 67 patients who underwent neck dissection, PET/CT had a PPV of 92.7%. The accuracy was 89.7% in 20 patients who had bilateral neck dissections. The unknown primary site was found in 72.7% (16/22) of patients with unknown primary HN cancer. Synchronous lesions were found in 8.1% of patients by PET/CT, with a PPV of 66.6%. Distant metastases were detected in 15.4% (19/123) of patients. Treatment was altered in 30.9% (38/123) of patients as a result of this imaging modality. CONCLUSIONS: The benefit of the PET/CT imaging modality resides in its fusion of anatomic detail of the HN region with the sensitivity of detecting tumors with increased metabolic activity at distant sites. Treatment was altered in 30.9% of our previously untreated HN cancer patients because of this imaging technique, with altered treatment including upstaging, diagnosing distant and unresectable disease, and working-up second primary malignancies. The false-positive findings did not result in additional morbidity to these patients. Although PET/CT is sensitive in detecting occult cervical nodal metastases, it does not yet have the ability to replace neck dissection as the diagnostic standard of care. This study supports the use of PET/CT in patients with newly diagnosed HN cancer because of its high PPV and superiority of detecting distant metastases and synchronous lesions.
Subject(s)
Fluorodeoxyglucose F18 , Head and Neck Neoplasms/diagnostic imaging , Positron-Emission Tomography , Radiopharmaceuticals , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Cohort Studies , Cost-Benefit Analysis , Disease-Free Survival , Female , Fluorodeoxyglucose F18/administration & dosage , Head and Neck Neoplasms/mortality , Humans , Infusions, Intravenous , Magnetic Resonance Imaging/economics , Male , Middle Aged , Positron-Emission Tomography/economics , Radiopharmaceuticals/administration & dosage , Retrospective Studies , Sensitivity and Specificity , Tomography, X-Ray Computed/economicsSubject(s)
Breast Neoplasms/diagnostic imaging , Breast Neoplasms/pathology , Image Processing, Computer-Assisted , Imaging, Three-Dimensional , Magnetic Resonance Imaging/methods , Software , Cost Control , False Positive Reactions , Female , Humans , Magnetic Resonance Imaging/economics , Magnetic Resonance Imaging/standards , Mammography , Sensitivity and SpecificityABSTRACT
Is magnetic resonance imaging (MRI) based target volume definition for treatment planning of vertebral metastasis effective under economic considerations. From 1994 to 1999, a total of 137 patients with bone metastases affecting the vertebral column underwent MRI of the cervical, thoracic, or lumbar spine for the treatment planning of palliative radiation therapy. The following radiation treatment consisted in a irradiation of the affected vertebral region up to a total dose of 30-40 Gy. The cost calculation for radiotherapy and magnetic resonance tomography was done using the common tariff model (EBM) of the German Health Insurances. In 73% of patients (101 patients), magnetic resonance imaging resulted in marked corrections of the irradiation fields which would have resulted in the necessity of treatment for recurrence in the case of treatment planning without MRI. Consequently, the higher cost of MRI of 345.00 DEM (176,40 EUR) lead to a saving of 497.00 DEM (254,11 EUR) compared to a recurrence treatment of 10 fractions and of 1,428.00 DEM (730,12 EUR) compared to 20 fractions. The transport expenses for the second treatment could be saved as well. Even under economic considerations MRI is effective.
Subject(s)
Magnetic Resonance Imaging/economics , Palliative Care/economics , Radiotherapy Planning, Computer-Assisted/economics , Spinal Neoplasms/secondary , Cost-Benefit Analysis , Germany , Humans , Models, Economic , National Health Programs/economics , Spinal Neoplasms/economics , Spinal Neoplasms/radiotherapyABSTRACT
PURPOSE: To analyze cost-effectiveness of magnetic resonance imaging and conventional enteroclysis in the assessment of fistulas and abscesses in patients with Crohn's disease (CD). METHODS: A decision analytic model was used to compare enteroclysis with MRI, performing a cost-effectiveness analysis of both diagnostic strategies. Data from 84 patients undergoing a clinical trial were used. Primary outcome was defined as one correctly diagnosed patient regarding Crohn's disease, fistulas, and abscesses, including true-positive and true-negative cases. Costs of the two procedures were estimated in German Marks (DM) using fee schedules. The influence of different definitions of effects was calculated. For all variables single and multiple sensitivity analyses were performed. RESULTS: Incremental cost effectiveness of MRI vs. enteroclysis was 3,119.33 DM per one additional correctly diagnosed patient. The results of sensitivity analyses suggest that MRI use in certain patient subgroups (patients at higher prevalence of CD, fistulas, and abscesses) even becomes more cost-effective. In this case one additional effect could be gained below 1,650 DM. CONCLUSIONS: From an economic perspective, decision makers should consider the use of MRI in the work-up of patients with Crohn's disease as an efficient procedure under certain conditions. To support treatment policies for physicians or insurance coverage of certain diagnostic strategies the costs possibly saved with MRI should also be considered.
Subject(s)
Abdominal Abscess/diagnosis , Crohn Disease/diagnostic imaging , Crohn Disease/diagnosis , Intestinal Fistula/diagnosis , Magnetic Resonance Imaging/methods , Abdominal Abscess/diagnostic imaging , Barium Sulfate , Cost-Benefit Analysis , Costs and Cost Analysis , Crohn Disease/economics , Enema , Female , Humans , Intestinal Fistula/diagnostic imaging , Magnetic Resonance Imaging/economics , Male , Middle Aged , RadiographyABSTRACT
With the introduction of multidetector technology in CT and the moveable table with integrated coil modules in MRI, the concept of multiorgan screening has become realistic. CT colonography and MR colonography are new radiologic techniques that promise to be highly sensitive colorectal screening examinations. This article reviews the current status and research directions in CT colonography and MR colonography, and compares these methods.